SCHEMBL22708445

SCHEMBL22708445

Clc1cccc2c1oc1ccc3cc(-c4ccccc4)ccc3c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 4/20 0.50
▸ PGR P06401 1/20 0.43
▸ PIM1 P11309 1/20 0.42
▸ CSNK2A2 P19784 1/20 0.42
▸ CSNK2B P67870 1/20 0.42
▸ PIM3 Q86V86 1/20 0.42
▸ PIM2 Q9P1W9 1/20 0.42
▸ TTR P02766 2/20 0.41
▸ CYP1A2 P05177 4/20 0.40
▸ CYP1A1 P04798 3/20 0.40
▸ ABCG2 Q9UNQ0 2/20 0.40
▸ FYN P06241 1/20 0.40
▸ MAPK3 P27361 1/20 0.40
▸ PAX8 Q06710 1/20 0.40
▸ ESR2 Q92731 3/20 0.38
▸ ESR1 P03372 2/20 0.38
▸ GPR84 Q9NQS5 1/20 0.37
▸ HSD17B1 P14061 2/20 0.37
▸ HSD17B2 P37059 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31393395 0.84 AHR (0.44) AHRPGRPIM1CSNK2A2CSNK2B
SCHEMBL22762275 0.83 AHR (0.42) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL15667149 0.82 AHR (0.57) AHRTTRCYP1A2CYP1A1ABCG2
SCHEMBL29597535 0.82 AHR (0.57) AHRTTRCYP1A2CYP1A1ABCG2
SCHEMBL24969296 0.81 PIM1 (0.49) AHRPGRPIM1CSNK2A2CSNK2B
SCHEMBL25567828 0.81 PIM1 (0.49) AHRPGRPIM1CSNK2A2CSNK2B
SCHEMBL31385551 0.81 PIM1 (0.49) AHRPGRPIM1CSNK2A2CSNK2B
SCHEMBL29693288 0.81 TTR (0.49) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL24969295 0.81 TTR (0.49) AHRPIM1CSNK2A2CSNK2BPIM3
SCHEMBL22762445 0.80 AHR (0.42) AHRPGRPIM1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 AHR 30/4885PGR 1993/4885PIM1 1126/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 AHR 30/4885PGR 1993/4885PIM1 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback